Qing Chang

Title: Qing Chang - Innovator in Antibody Development

Introduction

Qing Chang is a notable inventor based in the Bronx, NY (US). He has made significant contributions to the field of immunology, particularly in the development of human antibodies derived from non-human animals. His innovative work has the potential to impact the treatment of infections caused by specific pathogens.

Latest Patents

Qing Chang holds a patent for "Human antipneumococcal antibodies from non-human animals." This invention provides human antibodies that specifically bind to capsular polysaccharide (PPS-3). The patent outlines methods for producing these antibodies in non-human animals and for expressing them in various cell systems, including hybridomas and recombinant host cells. Additionally, the invention includes kits and pharmaceutical compositions that utilize these antibodies, along with methods for treating, inhibiting, or preventing infections caused by such pathogens.

Career Highlights

Qing Chang is associated with Abgenix, Inc., where he continues to advance his research and development efforts. His work is crucial in the ongoing fight against infectious diseases, showcasing his commitment to improving healthcare outcomes.

Collaborations

Qing has collaborated with esteemed colleagues, including Zhaojing Zhong and Liise-anne Pirofski, who contribute to the research environment at Abgenix, Inc. Their combined expertise enhances the potential for groundbreaking discoveries in the field of antibody development.

Conclusion

Qing Chang's innovative work in the development of human antibodies from non-human animals represents a significant advancement in immunology. His contributions are poised to make a lasting impact on the treatment of infections, highlighting the importance of continued research in this vital area.